Search Page
Save citations to file
Email citations
Email address has not been verified. Go to
My NCBI account settings
to confirm your email and then refresh this page.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial.
Lancet Oncol. 2025 May;26(5):559-570. doi: 10.1016/S1470-2045(25)00083-X. Epub 2025 Apr 29.
Lancet Oncol. 2025.
PMID: 40315882
Clinical Trial.
Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancers.
Johnson MJ, Sumstad D, Folsom TD, Slipek NJ, DeFeo AP, Growe M, Kadidlo D, Thyagarajan B, Starr TK, Lou E, Choudhry M, Moriarity BS, Webber BR, McKenna DH.
Johnson MJ, et al.
Cytotherapy. 2025 Oct;27(10):1229-1239. doi: 10.1016/j.jcyt.2025.06.007. Epub 2025 Jun 21.
Cytotherapy. 2025.
PMID: 40673842
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.